GLENMARK.BO | Glenmark Pharmaceuticals Limited Annual &

Annual Balance Sheets

(In INR)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	143.58 Billion	193.71 Billion	170.83 Billion	156.03 Billion	146.84 Billion	132.95 Billion
Total Current Assets	74.28 Billion	98.73 Billion	82.82 Billion	73.59 Billion	68.03 Billion	66.96 Billion
Cash And Short Term Investments	16.59 Billion	14.63 Billion	14.43 Billion	12.14 Billion	11.79 Billion	11.33 Billion
Cash and Cash Equivalents	16.59 Billion	14.43 Billion	14.1 Billion	11.38 Billion	11.1 Billion	9.36 Billion
Short Term Investments	1.74 Billion	203.78 Million	328.75 Million	763.99 Million	696.56 Million	1.96 Billion
Net Receivables	18.58 Billion	50.07 Billion	39.35 Billion	34.15 Billion	31.75 Billion	30.77 Billion
Inventory	25.13 Billion	29.77 Billion	24.99 Billion	22.76 Billion	21.35 Billion	22.52 Billion
Other Current Assets	13.97 Billion	11.53 Billion	2.77 Billion	3.63 Billion	1.73 Billion	1.55 Billion
Total Non-Current Assets	69.3 Billion	94.97 Billion	88 Billion	82.43 Billion	78.81 Billion	65.98 Billion
Net PPE	35.37 Billion	50.46 Billion	46.53 Billion	42.03 Billion	40.92 Billion	33.68 Billion
Good Will And Intangible Assets	13.34 Billion	24.34 Billion	22.85 Billion	23.34 Billion	21.82 Billion	17.37 Billion
Good Will	673.59 Million	736.19 Million	600.19 Million	580.11 Million	528.99 Million	547.35 Million
Intangible Assets	12.67 Billion	23.6 Billion	22.25 Billion	22.76 Billion	21.29 Billion	16.82 Billion
Long-Term Investments	8.59 Billion	473.54 Million	556.64 Million	518.95 Million	507.33 Million	448.72 Million
Tax Assets	10.49 Billion	18.05 Billion	16.86 Billion	15.34 Billion	14.55 Billion	13.89 Billion
Other Non Current Assets	1.49 Billion	1.63 Billion	1.2 Billion	1.18 Billion	997.55 Million	584.86 Million
Other Assets	1.00	-	-0.00	-	-	-
Total Liabilities	65.11 Billion	95.32 Billion	76.45 Billion	85.39 Billion	86.14 Billion	76.9 Billion
Total Current Liabilities	58.18 Billion	50.45 Billion	46.89 Billion	42.01 Billion	41.25 Billion	40.21 Billion
Account Payables	25.35 Billion	23.91 Billion	22.88 Billion	22.37 Billion	21.25 Billion	22.2 Billion
Tax Payables	2.9 Billion	1.05 Billion	931.2 Million	501.2 Million	407.13 Million	457.56 Million
Short Term Debt	10.79 Billion	5.8 Billion	11.9 Billion	8.72 Billion	9.11 Billion	8.74 Billion
Deferred Revenue	2.9 Billion	20.64 Billion	11.98 Billion	10.61 Billion	10.49 Billion	9.09 Billion
Other Current Liabilities	19.12 Billion	78.13 Million	122.19 Million	286.38 Million	393.63 Million	157.37 Million
Total Non Current Liabilities	6.92 Billion	44.86 Billion	29.55 Billion	43.38 Billion	44.88 Billion	36.69 Billion
Long-Term Debt	1.51 Billion	40.46 Billion	27.71 Billion	41.12 Billion	42.74 Billion	35.73 Billion
Deferred Revenue Non Current	-1.00	1.31 Billion	1.21 Billion	1.36 Billion	1.34 Billion	885.06 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	5.4 Billion	2.65 Billion	311.87 Million	600.75 Million	632.84 Million	6.3 Million
Other Liabilities	1.00	0.00	-	-	-	0.00
Total Equity	78.47 Billion	98.39 Billion	94.38 Billion	70.64 Billion	60.7 Billion	56.04 Billion
Stock Holders Equity	78.47 Billion	94.73 Billion	90.86 Billion	70.64 Billion	60.7 Billion	56.05 Billion
Common Stock	282.19 Million	282.17 Million	282.17 Million	282.17 Million	282.17 Million	282.17 Million
Retained Earnings	78.7 Billion	94.57 Billion	92.1 Billion	72.33 Billion	63.29 Billion	56.14 Billion
Accumulated other comprehensive income	78.19 Billion	17.13 Billion	17.13 Billion	17.13 Billion	17.13 Billion	17.13 Billion
Common Stock Equity	78.47 Billion	94.73 Billion	90.86 Billion	70.64 Billion	60.7 Billion	56.05 Billion
Capital Lease Obligation	1.51 Billion	2.79 Billion	2.91 Billion	2.98 Billion	3.17 Billion	2.31 Billion
Total Investments	8.59 Billion	473.54 Million	556.64 Million	518.95 Million	507.33 Million	447.72 Million
Total Debt	12.3 Billion	46.27 Billion	39.62 Billion	49.85 Billion	51.85 Billion	44.48 Billion
Net Debt	-4.28 Billion	31.84 Billion	25.51 Billion	38.47 Billion	40.75 Billion	35.12 Billion

Breakdown	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2	2023 Q1
Total Assets	-	143.58 Billion	143.58 Billion	-	200.06 Billion	-
Total Current Assets	16.59 Billion	74.28 Billion	74.28 Billion	11.23 Billion	112.66 Billion	14.69 Billion
Cash And Short Term Investments	16.59 Billion	16.59 Billion	16.59 Billion	11.23 Billion	13.49 Billion	14.69 Billion
Cash and Cash Equivalents	-	16.59 Billion	16.59 Billion	-11.23 Billion	11.22 Billion	-14.69 Billion
Short Term Investments	-	1.74 Billion	1.74 Billion	22.47 Billion	2.26 Billion	29.39 Billion
Net Receivables	-	18.58 Billion	18.58 Billion	-	32 Billion	-
Inventory	-	25.13 Billion	25.13 Billion	-	26.49 Billion	-
Other Current Assets	-	13.97 Billion	13.97 Billion	-	14.43 Billion	-
Total Non-Current Assets	-16.59 Billion	69.3 Billion	69.3 Billion	-11.23 Billion	87.39 Billion	-14.69 Billion
Net PPE	-	35.37 Billion	35.37 Billion	-	43.25 Billion	-
Good Will And Intangible Assets	-	13.34 Billion	13.34 Billion	-	24.26 Billion	-
Good Will	-	673.59 Million	673.59 Million	-	689.52 Million	-
Intangible Assets	-	12.67 Billion	12.67 Billion	-	23.57 Billion	-
Long-Term Investments	-	8.59 Billion	8.59 Billion	-	782.53 Million	-
Tax Assets	-	10.49 Billion	10.49 Billion	-	17.11 Billion	-
Other Non Current Assets	-16.59 Billion	1.49 Billion	1.49 Billion	-11.23 Billion	1.97 Billion	-14.69 Billion
Other Assets	-	1.00	1.00	-	-	-
Total Liabilities	-78.47 Billion	65.11 Billion	65.11 Billion	-	102.7 Billion	-
Total Current Liabilities	-	58.18 Billion	58.18 Billion	-	58.37 Billion	-
Account Payables	-	25.35 Billion	25.35 Billion	-	19.17 Billion	-
Tax Payables	-	2.9 Billion	2.9 Billion	-	1.23 Billion	-
Short Term Debt	-	10.79 Billion	10.79 Billion	-	11.38 Billion	-
Deferred Revenue	-	2.9 Billion	2.9 Billion	-	24.58 Billion	-
Other Current Liabilities	-	19.12 Billion	19.12 Billion	-	3.23 Billion	-
Total Non Current Liabilities	-78.47 Billion	6.92 Billion	6.92 Billion	-	44.33 Billion	-
Long-Term Debt	-	1.51 Billion	1.51 Billion	-	40.43 Billion	-
Deferred Revenue Non Current	-	-1.00	-1.00	-	3.88 Billion	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	-78.47 Billion	5.4 Billion	5.4 Billion	-	13.6 Million	-
Other Liabilities	-	1.00	1.00	-	-	-
Total Equity	78.47 Billion	78.47 Billion	78.47 Billion	97.35 Billion	97.35 Billion	98.39 Billion
Stock Holders Equity	78.47 Billion	78.47 Billion	78.47 Billion	97.35 Billion	93.27 Billion	98.39 Billion
Common Stock	-	282.19 Million	282.19 Million	-	282.17 Million	-
Retained Earnings	-	78.7 Billion	78.7 Billion	-	-	-
Accumulated other comprehensive income	78.47 Billion	78.19 Billion	78.19 Billion	93.27 Billion	282.17 Million	94.73 Billion
Common Stock Equity	78.47 Billion	78.47 Billion	78.47 Billion	97.35 Billion	93.27 Billion	98.39 Billion
Capital Lease Obligation	-	1.51 Billion	1.51 Billion	-	2.6 Billion	-
Total Investments	-	8.59 Billion	8.59 Billion	22.47 Billion	782.53 Million	29.39 Billion
Total Debt	-	12.3 Billion	12.3 Billion	-	51.81 Billion	-
Net Debt	-	-4.28 Billion	-4.28 Billion	11.23 Billion	40.58 Billion	14.69 Billion

Balance Sheet Charts

BioPharma Credit PLC

BPCR

Full Analysis

Annual Balance Sheets
Cotinga Pharmaceuticals Inc.

COTQF

Full Analysis

Annual Balance Sheets
REINO Capital S.A.

RNC

Full Analysis

Annual Balance Sheets
Shah Foods Limited

SHAHFOOD

Full Analysis

Annual Balance Sheets
Cognex Corporation

0I14

Full Analysis

Annual Balance Sheets
Azimut Exploration Inc.

AZM

Full Analysis

Annual Balance Sheets

Global Stocks Search

Glenmark Pharmaceuticals Limited (GLENMARK.BO)

Annual Balance Sheets

Balance Sheet Charts

BioPharma Credit PLC

Cotinga Pharmaceuticals Inc.

REINO Capital S.A.

Shah Foods Limited

Cognex Corporation

Azimut Exploration Inc.